Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
about
Smoking Exposure and Survival of Patients with Esophagus Cancer: A Systematic Review and Meta-AnalysisEvidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, AnastomosisGlobal DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients.A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide.A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinomaEvolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagusFactors Influencing Compliance to Radical Treatment of Middle Thoracic Esophageal Cancer: An Audit from a Regional Cancer Centre.5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1.Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database.Clinicopathological features and prognosis of patients <45 years old with esophageal adenocarcinoma comparing to other age groupsPrognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.Web-Based Immersive Virtual Patient Simulators: Positive Effect on Clinical Reasoning in Medical Education.Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.Time trends of esophageal and gastric cancer mortality in China, 1991-2009: an age-period-cohort analysis.Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.Potential role of P2X7R in esophageal squamous cell carcinoma proliferationPTEN loss is associated with a poor response to trastuzumab in HER2-overexpressing gastroesophageal adenocarcinoma.Esophageal cancer: The latest on chemoprevention and state of the art therapies.Is Clinical Research in Oesophageal Cancer in South Africa in Crisis? A Systematic Review.Screening and Preventive Strategies in Esophagogastric Cancer.Nutrition in peri-operative esophageal cancer management.An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk.Efficacy of endoscopic management of leak after foregut surgery with endoscopic covered self-expanding metal stents (SEMS).Racial Disparity in Gastrointestinal Cancer Risk.Clinical characteristics and associated factors of Japanese patients with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study.The influence of Helicobacter pylori on the ethnic distribution of Barrett's metaplasia.First reports of esophageal adenocarcinoma with white globe appearance in Japanese and Caucasian patients.The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.Esophageal Endoscopic Submucosal Dissection Assisted by an Overtube with a Traction Forceps: An Animal Study.Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.Circulating microRNAs as potential biomarkers to detect transformation of Barrett's oesophagus to oesophageal adenocarcinoma.Sites of metastasis and overall survival in esophageal cancer: a population-based study.Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.Protein-Protein Interaction Network Analysis for a Biomarker Panel Related to Human Esophageal Adenocarcinomap38 predicts depression and poor outcome in esophageal cancer.A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma.Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma.Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.
P2860
Q26748758-C2FD7741-E9F2-405F-8DD2-F5F6982B9B40Q26753866-18C1E1A1-0ECD-426F-A05B-B4BACAFDA924Q30826635-CF797768-C95F-449E-99E5-90ED971E1162Q35992342-32EE561A-EC39-4386-B593-433BEAAF53D1Q36074627-1D68BC1B-BEB5-4AEE-B7DE-6F5F9E3B4654Q36287407-B76B8CD7-73B9-46B5-B878-6DAB2293E53BQ36968814-0F7355E8-B0DD-4A00-8612-CA71A661B4EEQ37151826-9B755741-6E3E-4552-9C85-2418421CB12CQ37269937-6761C152-FAEF-4207-854E-FDE573E7D651Q37361998-B79255B0-60D8-43C0-BA68-9BD320AD02C4Q37411124-68FDB464-4157-4107-9C72-A6875A18921FQ37457478-C6032293-BB4D-4C8B-BC49-DE3EBBA55C42Q38546830-B682ED9F-B9A1-460A-A12B-3ACB6605E6C1Q38637648-4484A8A1-F6C5-4E0A-A5A2-927C908CDBF9Q38654295-6D9482DC-7FFB-4D49-BE4D-56087AECE247Q38686553-197B042B-F962-4E54-AB40-A4E6C1BC1FEEQ38708131-58979C99-E961-4A8B-A7C7-844AB540FDE9Q38752291-01B2079A-9BE2-4FA9-81CE-348DDC10B64CQ38938101-7E8F953E-0286-4566-86F5-A2E34BBB5E77Q38997144-8555CAEE-B536-4FC4-B843-752CCA5B35F0Q39171528-7A1AF70E-F562-4B35-8E39-D6370A915EEBQ39270534-9CDED306-5D7B-49BC-BBB7-D092DAAD4AFCQ39407488-D3253864-D21D-4EC3-82A6-9FF4A6209E37Q39674194-D2042600-CA55-4993-95CB-5968D63D743EQ40083252-46C1388F-2FF5-4765-9C75-35671BC2F4BAQ40213597-E696C233-EE22-4211-AD57-535A21BB891BQ40445712-8D3B7D7B-E58D-4047-B26F-C4A5AF93A609Q41458246-35BA694F-CBEF-4FF0-8E73-DC06BD4A4F03Q41851530-F3333F94-7AAD-4232-802D-A75788407119Q42369307-21B305AA-A350-4149-9197-45DA2CE8F614Q42705165-D5AB3F13-693F-43B0-8449-ABE099A072A2Q46249728-410DFD22-B6F9-4052-A4C6-01B85CC31EBAQ46475867-D52FA87C-00A6-404E-97AD-0D53E8CA3393Q47097386-C568FA6B-8EE3-432D-A4AE-4FCF28B0F103Q47154860-2B28E56F-F862-40E1-A2C7-8EDAD4396BD9Q47245519-C13F38A6-5BA1-499B-A67B-4960796B11C3Q47653126-7EA3D32B-9EFD-466A-98F2-8CEBDEEDCC14Q47758452-00CA0201-7209-41C5-95CD-2DD08AAADB15Q47947064-CAE9D4D8-06BA-435E-90A7-DB91C10D0AFCQ49251004-2F009DFC-BFFB-45BC-850A-54425FF14942
P2860
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@ast
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@en
type
label
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@ast
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@en
prefLabel
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@ast
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@en
P2860
P1433
P1476
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
@en
P2093
Joel H Rubenstein
P2860
P304
P356
10.1053/J.GASTRO.2015.04.053
P407
P577
2015-05-07T00:00:00Z